Edelweiss MSCI India Domestic & World Healthcare 45 Index Growth Direct Plan
SIP amount
Min. ₹100
Lumpsum amount
Min. ₹100

Edelweiss MSCI India Domestic & World Healthcare 45 Index Growth Direct Plan

NAV
₹19.9843
+0.11%
(13 Jun)
AUM
156 Cr
TER
0.51%
Risk
Very High Risk
Insights
Net Asset Value (NAV) is above its 200 days moving average
Total Expense Ratio (TER) is in the top 25% of comparable funds
In beta. Send feedback here.
Compare with other fund
1Y
+10.2%
+8.1%
+7.0%
+6.6%
+6.3%
3Y
+20.2%
+29.5%
+29.6%
+29.4%
+28.0%
5Y
NA
NA
NA
NA
+32.0%
ALL
+16.1%
+24.0%
+20.1%
+21.5%
+26.5%
VOL
12.2%
17.6%
20.9%
20.2%
19.1%
TER
0.5%
0.3%
0.5%
0.3%
0.3%
AUM
₹156 Cr
₹446 Cr
₹212 Cr
₹487 Cr
₹2,312 Cr
INFO
1.32
1.36
0.96
1.07
1.39
Past performance
Past performance is no guarantee of future returns.
Had you invested
Over the last
1Y
3Y
ALL
Your returns would have been
Edelweiss MSCI India Domestic & World Healthcare 45 Index (G)
₹1,00,00,00,000
14.0%
Fixed deposit
₹40,00,00,000
6.0%
Bank savings
₹40,00,00,000
3.0%
See fund holdings as of 30th Apr
Top holdings
Sun Pharmaceuticals Industries Ltd
13.1%
Max Healthcare Institute Ltd Ordinary Shares
6.3%
Cipla Ltd
6.0%
Eli Lilly and Co
5.8%
Divi's Laboratories Ltd
5.4%
Apollo Hospitals Enterprise Ltd
5.2%
Dr Reddy's Laboratories Ltd
5.1%
Lupin Ltd
3.6%
Johnson & Johnson
3.0%
Torrent Pharmaceuticals Ltd
2.9%
Top industry exposure
Healthcare
99.5%
Other information
Minimum SIP
₹100
Minimum lumpsum
₹100
Additional lumpsum
₹100
Portfolio turnover
-
Lock-in period
-
Exit load
No exit load
Fund objective
The Scheme will invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors. However, there is no assurance that the investment objective of the Scheme will be realized and the Scheme does not assure or guarantee any returns.
Fund manager(s)
Bhavesh Jain
Amit Vora

FAQs